Date: 2014-04-15
Type of information: Financing round
Company: Mucosis (The Netherlands)
Investors: Changchun BCHT Biotechnology Co (China), BioGeneration Ventures (The Netherlands), MedSciences Capital (The Netherlands), NV NOM (Investment and Development Agency for the Northern Netherlands) (The Netherlands), Utrecht Holdings (The Netherlands)
Amount: € 5 million
Funding type: financing round
Planned used:
Others: * On April 15, 2014, Mucosis has announced that it entered into a long-term collaboration and license agreement with China-based Changchun BCHT Biotechnology Co (BCHT) and raised € 5 million, in a new financing round. In addition to BCHT, the financing round was supported by Mucosis’s current investors, which include BioGeneration Ventures, MedSciences Capital, NV NOM (Investment and Development Agency for the Northern Netherlands), and Utrecht Holdings.
Therapeutic area: Infectious diseases - Respiratory diseases
